HKSE - Delayed Quote HKD

Alphamab Oncology (9966.HK)

Compare
7.910
-0.390
(-4.70%)
At close: April 3 at 4:08:15 PM GMT+8

Research Analysis

Revenue vs. Earnings

Revenue --
Earnings --

Q2'20

0
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Analyst Price Targets

2.48 Low
4.31 Average
7.910 Current
7.03

Earnings Estimate

Currency in USD Current Qtr. (Jan 1970)Next Qtr. (Jan 1970)Current Year (2025)Next Year (2026)
No. of Analysts ----22
Avg. Estimate 00-0.19-0.11
Low Estimate 00-0.2-0.14
High Estimate 00-0.18-0.08
Year Ago EPS ----0.17-0.19

Revenue Estimate

Currency in USD Current Qtr. (Jan 1970)Next Qtr. (Jan 1970)Current Year (2025)Next Year (2026)
No. of Analysts ----33
Avg. Estimate ----431.78M719.79M
Low Estimate ----318.03M495.54M
High Estimate ----517.6M913.8M
Year Ago Sales ----640.08M431.78M
Sales Growth (year/est) -----32.54%66.70%

EPS Trend

Currency in USD Current Qtr. (Jan 1970)Next Qtr. (Jan 1970)Current Year (2025)Next Year (2026)
Current Estimate 00-0.19-0.11
7 Days Ago 00-0.19-0.11
30 Days Ago 00-0.17-0.01
60 Days Ago 00-0.17-0.01
90 Days Ago 00-0.17-0.01

EPS Revisions

Currency in USD Current Qtr. (Jan 1970)Next Qtr. (Jan 1970)Current Year (2025)Next Year (2026)
Up Last 7 Days --------
Up Last 30 Days --------
Down Last 7 Days ----11
Down Last 30 Days ----21

Growth Estimates

Current Qtr.Next Qtr.Current YearNext Year
9966.HK -----211.05%42.55%
S&P 500 6.68%6.74%9.91%14.34%

Related Tickers